Page 38 - 71_02

GEOFFREY BURNSTOCK AN. R. ACAD. NAC. FARM.

fro the different P2 receptor subtypes, therapeutic strategies are likely
to include agents that control the expression of P2 receptors,
inhibitors of extracellular breakdown of ATP and enhancers or
inhibitors of ATP transport. Investigating the interactions of
purinergic signalling with other established signalling systems will
also be important.

REFERENCES

(1) BURNSTOCK, G. AND KNIGHT, G. E. (2004): Int. Rev. Cytol. 240: 31-304.
(2) RALEVIC, V. AND BURNSTOCK, G. (1998): Pharmacol. Rev. 50: 413-492.
(3) BURNSTOCK, G. (2002): Clinical Medicine 2: 45-53.
(4) AGTERESCH, H. J.; DAGNELIE, P. C.; VAN DER BERG, J. W. O. AND WILSON, J. H.
(1999): Drugs 58: 211-232.
(5) BURNSTOCK, G. (2002): Arteriosclerosis, Thrombosis and Vascular Biology 22:
364-373.
(6) YANG, A.; SONIN, D.; JONES, L.; BARRY, W. H. AND LIANG, B. T. (2004): Am. J.
Physiol 287: H1096-H1103.
(7) DI, V. F. AND SOLINI, A. (2002): Br. J. Pharmacol. 135:831-842.
(8) GREIG, A. V. H.; LINGE, C.; TERENGHI, G.; MCGROUTHER, D. A. AND BURNSTOCK, G.
(2003): J. Invest. Dermatol. 120: 1007-1015.
(9) BURNSTOCK, G. (2001): Purinergic signalling in gut. In Abbracchio, M. P. and
Williams, M. editors. Handbook of Experimental Pharmacology, Volume 151/
(10) II. Purinergic and Pyrimidinergic Signalling II-Cardiovascular, Respiratory,
Immune, Metabolic and Gastrointestinal Tract Function,Springer-Verlag,
(11) Berlin, pp. 141-238.
(12) WYNN, G.; BEI, M.; RUAN, H-Z. AND BURNSTOCK, G. (2004): Am. J. Physiol
(13) Gastrointest Liver Physiol 287: G647-G657.
GALLIGAN, J. J. (2004): Br. J. Pharmacol. 141: 1294-1302.
(14) BURNSTOCK, G. (2001): Trends Pharmacol. Sci. 22: 182-188.
DI VIRGILIO, F.; FALZONI, S.; MUTINI, C.; SANZ, J. M. AND CHIOZZI, P. (1998): Drug
(15) Dev. Res. 45: 207-213.
(16) LAMMAS, D. A.; STOBER, C.; HARVEY, C. J.; KENDRICK, N.; PANCHALINGAM, S. AND
(17) KUMARARATNE, D. S. (1997): Immunity. 7: 433-444.
LEMAIRE, I. AND LEDUC, N. (2004): Drug Dev. Res. 59: 118-127.
(18) WAEBER, C. AND MOSKOWITZ, M. A. (2003): Neurology 61: S9-20.
HOEBERTZ, A.; ARNETT, T. R. AND BURNSTOCK, G. (2003): Trends Pharmacol. Sci.
(19) 24: 290-297.
KORCOK, J.; RAIMUNDO, L. N.; KE, H. Z.; SIMS, S. M. AND DIXON, S. J. (2004): J.
Bone Miner. Res. 19: 642-651.
DELL’ANTONIO, G.; QUATTRINI, A.; CIN, E. D.; FULGENZI, A. AND FERRERO, M. E.
(2002): Artritis Rheum 46: 3378-3385.

318